|
AMMECR1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64749999997937E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.46059999650561E-08 |
| Normal-vs-Stage2 |
1.545620E-02 |
| Normal-vs-Stage3 |
2.167800E-04 |
| Normal-vs-Stage4 |
9.428100E-02 |
| Stage1-vs-Stage2 |
3.276200E-01 |
| Stage1-vs-Stage3 |
8.196400E-01 |
| Stage1-vs-Stage4 |
2.317200E-01 |
| Stage2-vs-Stage3 |
5.192600E-01 |
| Stage2-vs-Stage4 |
7.391600E-01 |
| Stage3-vs-Stage4 |
3.507600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.77929999995086E-06 |
| Normal-vs-AfricanAmerican |
1.54970999999282E-05 |
| Normal-vs-Asian |
3.153600E-01 |
| Caucasian-vs-AfricanAmerican |
1.723370E-01 |
| Caucasian-vs-Asian |
5.991800E-01 |
| AfricanAmerican-vs-Asian |
2.382400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.44059999999768E-05 |
| Normal-vs-Female |
2.34659999986953E-07 |
| Male-vs-Female |
5.242400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.812370E-02 |
| Normal-vs-Age(41-60Yrs) |
1.158300E-04 |
| Normal-vs-Age(61-80Yrs) |
3.60809999999656E-06 |
| Normal-vs-Age(81-100Yrs) |
8.41240000000187E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.218200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.567400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.274200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.116800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.152020E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.507400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.508200E-02 |
| Normal-vs-Grade 2 |
1.581680E-04 |
| Normal-vs-Grade 3 |
8.51209991381552E-10 |
| Normal-vs-Grade 4 |
4.737800E-02 |
| Grade 1-vs-Grade 2 |
9.246800E-01 |
| Grade 1-vs-Grade 3 |
4.507400E-01 |
| Grade 1-vs-Grade 4 |
8.934400E-01 |
| Grade 2-vs-Grade 3 |
6.887800E-02 |
| Grade 2-vs-Grade 4 |
9.339800E-01 |
| Grade 3-vs-Grade 4 |
3.914200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.96040000291597E-08 |
| Normal-vs-ccB subtype |
1.359570E-03 |
| ccA subtype-vs-ccB subtype |
1.531760E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.875670E-03 |
| Normal-vs-N1 |
4.318400E-01 |
| N0-vs-N1 |
6.376600E-01 |
|
|
